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stress, more damage may be caused to the AAA wall, possibly leading to progression of the
aneurysm and reflection in up- or downregulation of specific circulating biomarkers. Levels
of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1, C-reactive
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Methods: Thirty-seven patients (maximum AAA diameter 41e55 mm) with two, three or four
consecutive computed tomography angiography (CTA) scans were prospectively included.
Diameter growth rate in mm/year was determined between each pair of two sequential CTA
scans. AAA wall stress was computed by finite element analysis, based on the first of the
two sequential CTA scans only (nZ 69 pairs). Biomarker information was determined in 46
measurements in 18 patients. The relation between AAA diameter and wall stress was deter-
mined and the AAA’s were divided into three equally sized groups (relative low, medium and
high stress). Growth rate and biomarker concentrations were compared between these groups.
Additionally, correlation coefficients were computed between absolute wall stress, AAA
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AAA Wall Stress, Growth and Biomarkers 411Results: A relative low AAA wall stress was associated with a lower aneurysm growth rate.
Growth rate was also positively related to MMP-9 plasma concentration (rZ 0.32). The average
MMP-9 and CRP concentrations increased with increasing degrees of relative wall stress,
although the absolute and relative wall stress did not correlate with any of the biomarkers.
Conclusion: Although lower relative wall stress was associated to a lower AAA growth rate, no
relation was found between biomarker concentrations and wall stress. Future research may
focus on more and extensive biomarker measurements in relation to AAA wall stress.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Incidence of abdominal aortic aneurysm (AAA) is increasing
due to general aging of the population and an increase in
the amount of screening programs.1,2 If left untreated, an
AAA will increase in size until rupture of the aortic wall
occurs, causing a life-threatening hemorrhage. Growth rate
of an AAA is generally defined as the change in maximum
aortic diameter over a certain time period. Previous studies
indicate that AAA growth rate increases with the diameter
of the AAA.3,4 However, this growth rate is not identical for
all AAA’s, as some AAA’s remain stable for a considerable
period of time, while others show a strong increase in
diameter over a short period. Also, some AAA’s tend to grow
discontinuously, with alternating periods of growth and
non-growth.5,6
Recently, multiple studies have focused on patient-
specific AAA wall stress analyses.7e11 Peak wall stress was
found to be significantly higher for patients with symp-
tomatic or ruptured AAA’s than for asymptomatic aneu-
rysms.7,10 However, in these studies, the relation between
wall stress and AAA growth rate was not investigated. With
increasing wall stress, more damage may occur in the AAA
wall, leading to degeneration of the wall and expansion of
the aneurysm. Wall stress may thus have a prominent role
in aneurysm growth and computing AAA wall stress may
lead to a predictive model for AAA growth rate.
Circulating biomarkers are believed to reflect inflam-
mation and degeneration in the AAA wall.12 Matrix metal-
loproteinase-9 (MMP-9) is involved in the breakdown of the
extracellular matrix and a higher plasma MMP-9 concen-
tration was associated with AAA presence.12 Additionally,
MMP-9 significantly correlated with AAA growth rate.13 The
activity of MMP’s is, amongst others, controlled by tissue
inhibitor of the metalloproteinases-1 (TIMP-1). Although
plasma concentrations of TIMP-1 were found to be signifi-
cantly higher in AAA’s than in healthy controls,14 TIMP-1
levels were found to be lower in AAA wall tissue compared
to healthy aortic tissue.15 C-reactive protein (CRP) is a non-
specific acute phase protein that is rapidly expressed in
inflammation and has been previously linked to AAA size.16
Recently, alpha 1-antitrypsin (a1-AT), an inhibitor of serine
proteases such as trypsin and leukocyte elastase, was
correlated with AAA growth.17
Summarizing, AAA’s with a relative high wall stress may
experience more damage to the AAA wall, possibly leading
to faster expansion of the aneurysm. The amount of AAA
wall damage may be reflected by up- or downregulation of
specific circulating biomarkers. In this study, the relation
between AAA wall stress, AAA growth rate, and biomarkerconcentrations was evaluated. First, the relation between
the maximum diameter and wall stress was determined,
and AAA’s with relative high, medium and low wall stress,
relative to their diameter, were identified. Prospective AAA
diameter growth rate was determined and compared for
each of the wall stress groups. The concentrations of MMP-
9, TIMP-1, highly sensitive measured CRP (hs-CRP) and a1-
AT were studied in relation to the computed wall stress and
the prospective AAA growth rate.
Methods
Thirty-seven patients with asymptomatic AAA (initial
maximum diameter 41e55 mm) from the Catharina Hospital
Eindhoven (the Netherlands, nZ 19) and the University
Medical Center Maastricht (the Netherlands, nZ 18) were
prospectively included in the study. CTA scans were made
with a 4-month interval until either the patient was eligible
for surgery or the maximum of 4 consecutive CTA scans was
reached. The patients were included for a 1-year follow-up
with CTA, thereafter, regular ultrasound surveillance was
continued. Blood pressures were measured within 30 min
after the CTA scan. Growth in AAA diameter was deter-
mined as the change in maximum anterioreposterior
diameter between two consecutive CTA measurements,
and was converted to mm/year. Venous blood was drawn
via an antecubital vein puncture and collected in SST
(serum) and EDTA (plasma) buffered vacutainers. Exactly
30 min after collection, the blood was centrifuged (15 min,
3000g, 4 C) and multiple aliquots were stored at 80 C,
exactly 1 h after collection, until further analyses.
Patient demographical information (age, gender,
hypertension, smoking, diabetes mellitus and statin use)
was collected at every measurement and updated at each
visit. Research approval was given by the local Medical
Ethics Commissions of the hospitals involved. All patients
signed informed consent prior to inclusion in the study.
Biomarker analysis
Biomarker analyses were only performed on the blood
samples of the 18 patients from the University Medical
Center Maastricht. Plasma levels of MMP-9 and TIMP-1 were
determined in duplo by means of commercial available
ELISA (GE Healthcare, Upsala, Sweden). The duplo
concentration measurements results in two independent
values, and whenever these values deviated less than 10%
of each other, the values were averaged. Otherwise, the
measurements were discarded in the analyses. The sero-
logical levels of a1-AT and hs-CRP were routinely
Inclusion
37 (18)
FU 1 (t=4 m)
37 (16)
Total:106 (46) Total:69
Growth 37
Exit 0 (2)
Growth 21
Exit 16 (4)
Growth 11
Exit 10 (12)
21 (12)
FU 2 (t=8 m)
11 (-)
FU 3 (t=12 m)
Figure 1 The patient flow chart indicating the number of
patients with CTA at inclusion and at 4, 8 and 12-month follow-
up. In brackets is indicated how many patients were included
in the biomarker analysis. The right side indicates the number
of patients who were lost between each follow-up and the
number of AAA’s used for growth analysis.
412 L. Speelman et al.determined on the BN Prospec (Dade Behring Inc., Dear-
field, USA).
Wall stress analysis
Automatic segmentation of the AAA’s from the contrast
enhanced CTA data was done as described previously.11 No
thrombus or calcifications were incorporated in the finite
element model, but the relative thrombus volume18 and
calcification index19 were determined for each model. The
segmentation of the AAA wall was used as input to create
a finite element mesh. A mesh typically consisted of40 42 44 46 48 50 52 54 56 58
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Figure 2 Regression model between maximum aortic diameter an
residuals of the regression model, divided by the standard deviatioapproximately 30,000 quadratic 15-node tetrahedral
elements, and a constant wall thickness of 2 mm was
applied. A mesh refinement study was performed prior to
the analyses and showed that the wall stress results
changed less than 1% for an increasing number of elements.
The finite element software Sepran (Sepra, Delft, the
Netherlands) was used to calculate AAA wall stresses. The
governing equations of momentum and continuity were
solved and the most distal and proximal planes of the
models were constrained in all directions as essential
boundary conditions. The nonlinear material model as
proposed by Raghavan and Vorp (2000) was used to model
the aortic wall behavior.20 The patient group averaged
systolic blood pressure of 140 mmHg (18.7 kPa) was applied
to the inner wall of the finite element model. No cardiac
triggering was applied in the CTA imaging protocol, there-
fore, the AAA geometry as derived from the CTA, was
subjected to a time-averaged blood pressure. This results in
initial stress in the AAA wall, which was accounted for using
the backward incremental (BI) method.21,22 The mean
arterial pressure, as measured after the CTA scan, was used
for that purpose.
Stresses, strains and displacements were calculated
throughout the whole aneurysm model. In each node,
maximum principal stress was computed. 99-Percentile
wall stress in the AAA was used as stress measure,
computed as the highest stress, after exclusion of 1% of the
nodes in the mesh, with the highest stress. 99-Percentile
wall stress showed to be more reproducible and less
sensitive to geometrical variations than peak AAA wall
stress.11
Data analysis
Based on the law of Laplace it may be expected that AAA
wall stress generally increases with diameter. A regression
model between the maximum AAA diameter and 99-
percentile wall stress was therefore determined for all AAA
models. The residuals of the regression model were
normalized with the standard deviation of the model, and
the AAA’s were divided into three equally sized groups
(relative high, medium and low stress), based on the40 42 44 46 48 50 52 54 56 58
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Table 1 Demographics for relative low, medium and high stress AAA’s.
Relative wall stress Low (nZ 23) Medium (nZ 23) High (nZ 23) p-Value
Gender (M:F) 23:0 23:0 18:5 <0.01
Age (mean(std)) years 73 (6) 72(6) 70 (6) 0.31a
Smoking (never:ex:current) 1:20:2 3:14:6 4:13:6 0.17
Hypertensionc 11 13 16 0.50
Statin-use 13 7 13 0.20
Diabetes mellitus Type I 1 2 0 0.32
Max diameter (mean(std)) mm 46 (4) 49 (4) 47 (4) 0.14a
Relative thrombus volume (mean(std)) % 23 (29) 39 (29) 34 (30) 0.16a
Calcification index (mean (std)) % 20 (16) 19 (15) 13 (9) 0.24a
AAA growth rate (median (IQR)) mm/y 0 (3) 3 (7.5) 3 (8.3) 0.06b
Pearson chi-square test unless stated otherwise.
a Independent t-test.
b KruskaleWallis test.
c Hypertension is defined as a consistent blood pressure of at least 140 mmHg systolic or 90 mmHg diastolic.
AAA Wall Stress, Growth and Biomarkers 413normalized residuals. Patient demographics, relative
thrombus volume,18 calcification index19 and prospective
AAA growth were compared for each stress group. The log
levels of MMP-9, TIMP-1, a1-AT and hs-CRP were compared
between the high, medium and low stress AAA’s, using
ANOVA. As the biomarkers may influence each other on
different levels, partial correlation coefficients were
computed for both AAA growth rate and wall stress, in
relation with log levels of the biomarkers. In that case, the
strength of the relation between two variables is measured,
after adjusting for the relations with other variables
included in the evaluation. A p-value <0.05 was considered
significant. The data analyses were performed with Stat-
graphics Centurion XV (StatPoint, Herndon, Virginia, USA).
Results
A total of 106 CTA scans were made (range 2e4 scans per
patient). The median AAA diameter in these scans was-3
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Figure 3 Box-and-Whisker plots of the AAA diameter growth
rate for low, medium and high stress groups with the Kruskale
Wallis p-values. The KruskaleWallis test p-value was 0.06 for
growth rate between all groups.46 mm (range 41e57 mm). Of each pair of two sequential
CTA scans, the diameter growth rate was determined and
only the first of the two sequential scans was used for wall
stress analyses, leaving in total 69 growthestress compar-
isons in 37 patients (Fig. 1). During the study, four patients
reached a diameter of 55 mm or more and were scheduled
for aneurysm repair.
The left image of Fig. 2 shows the relation between the
maximum AAA diameter and 99-percentile wall stress for
the 69 measurements (rZ 0.47, p-value <0.01). The
residuals of the regression model were normalized by the
standard deviation (STD) of the model and three equally
sized groups were formed with relative low, medium and
high stress (Fig. 2 right). The thresholds to form the groups
were 0.5 STD.
Patient demographics of the three stress groups are
summarized in Table 1. Gender was significantly different
between the groups, as all female patients had a relative
high AAA wall stress. The relative thrombus volume and
calcification index were not significantly different between
the groups (p-values 0.16 and 0.24, respectively). The AAA
growth rate per group is displayed in the Box-and-Whisker
plot in Fig. 3. The growth rate of the low stress group was
significantly lower than of the medium stress group (Krus-
kaleWallis p-value 0.02). The difference in growth rate
between the low and high wall stress groups was close to
significant (KruskaleWallis p-value 0.08).
Biomarker concentrations were determined in 18
patients, with total 46 measurements (see Fig. 1). Deter-
mined biomarker levels were inaccurate and discarded for 3
TIMP-1 measurements and the data of 6 hs-CRP and a1-AT
analyses were missing. The log transferred biomarker
concentrations for relative low, medium and high stress
groups are given in Table 2. p-Values were computed with
ANOVA. The mean plots of the MMP-9 and hs-CRP levels are
displayed in Fig. 4. Although the average levels of MMP-9 and
hs-CRP showed an increasing trend with relative wall stress,
no significant differences were found in the log levels of any
of the biomarkers between the three stress groups.
Partial correlations between absolute 99-percentile wall
stress and the log levels of the biomarkers are shown in
Table 3. Significant correlations between MMP-9 and TIMP-1
Table 2 Biomarker concentrations (median (IQR)) for low, medium and high stress AAA models (46 measurements in 18
patients). ANOVA p-values for the log levels of the biomarkers are given and the number of measurements are displayed below
the concentration values.
Wall stress Low Medium High All p-Value
MMP-9 (ng/mL) 34 (22e38) (nZ 18) 43 (22e64) (nZ 16) 49 (24e53) (nZ 12) 41 (22e50) (nZ 46) 0.52
TIMP-1 (ng/mL) 129 (109e159) (nZ 17) 134 (98e163) (nZ 15) 130 (91e151) (nZ 11) 131 (98e163) (nZ 43) 0.54
hs-CRP (mg/L) 2.3 (1.4e3.1) (nZ 14) 3.3 (1.4e5.0) (nZ 17) 3.7 (1.2e6.1) (nZ 9) 3.0 (1.3e4.2) (nZ 40) 0.67
a1-AT (g/L) 1.6 (1.2e1.8) (nZ 14) 1.6 (1.5e1.8) (nZ 17) 1.6 (1.5e1.8) (nZ 9) 1.6 (1.5e1.8) (nZ 40) 0.88
414 L. Speelman et al.(rZ0.38, p-value 0.03), MMP-9 and hs-CRP (rZ 0.32, p-
value 0.01), and between TIMP-1 and a1-AT (rZ0.55, p-
value <0.01) were found. AAA wall stress did not correlate
with any of the biomarkers.
Table 4 shows the partial correlations between AAA
growth rate and log levels of the biomarkers. It must be
noted that the correlation coefficients between the
biomarkers mutually in Tables 3 and 4 do not exactly
coincide due to the fact that partial correlations were
computed. By doing so, the correlation between two vari-
ables is computed after adjusting for the relations with
other variables included in the evaluation. Besides the
previously found significant correlations between the
biomarkers mutually, AAA growth rate showed to be
significantly related to MMP-9 plasma concentration
(rZ 0.32, p-value <0.05). This was also significant for the
univariate correlation between AAA growth rate and MMP-9
concentration (rZ 0.34, p-value 0.02).Discussion
In this study we hypothesized that in AAA’s with high wall
stress, relative to the diameter, the wall is more exten-
sively damaged and degenerated than average. This could
be reflected by increased AAA growth rate and up- or
downregulation of specific biomarkers. The results showed
that a relative medium or high wall stress could be associ-
ated with a higher growth rate, which was significant
between the medium and low wall stress groups (p-value
0.02), and close to significant between the high and low
wall stress groups (p-value 0.08). Although the average
levels of MMP-9 and hs-CRP showed an increasing trend for25
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Figure 4 Means and Tukey HSD confidence intervals of the actu
stress groups. ANOVA p-values were computed with log-transformeincreasing relative wall stress, none of the MMP-9, TIMP-1,
a1-AT and hs-CRP concentrations were significantly
different between the stress groups (Table 2). The average
concentration of hs-CRP in the medium and high stress
groups exceeded 3 mg/L, which was previously identified as
threshold level between average and higher relative risk for
future vascular events.23 The growth rate in these groups
was also higher than for the low stress group. A positive
relation between MMP-9 concentration and AAA growth rate
was found, but no correlation between absolute AAA wall
stress and biomarkers could be identified.
The maximum aneurysm diameter and the corresponding
99-percentile wall stress showed a significant positive
relation (rZ 0.47, p-value <0.01). The relative low,
medium and high wall stress groups as determined from this
stressediameter relation, did not show significant differ-
ences in age, smoking, hypertension, use of statins and
diabetes mellitus. The maximum AAA diameter, relative
thrombus volume and calcification index were also not
different between the wall stress groups. The fact that all
female patients resided in the high stress AAA group may be
explained by geometrical differences in AAA’s between
men and women. Due to a smaller initial diameter, AAA’s of
equal size have a greater proportional dilatation in females
than in males,24 which generally results in a stronger
curvature at inflection points on the wall surface. As in
most cases high stress areas are situated at inflection
points,11 this can result in a higher 99-percentile wall
stress. A larger patient population should be evaluated to
elaborate on the differences in wall stress between male
and female patients.
Between the biomarkers mutually, a positive correlation
was found between hs-CRP and MMP-9 (Tables 3 and 4),1.5
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al MMP-9 and hs-CRP concentrations for low, medium and high
d concentration (p-values 0.52 and 0.67, respectively).
Table 3 Partial correlation coefficient matrix between wall stress and log levels of MMP-9, TIMP-1, hs-CRP and a1-AT. The
upper right part shows the correlation coefficients and the number of measurements, the lower left part shows the corre-
sponding p-values. The * indicates a significant correlation.
Stress MMP-9 TIMP-1 hs-CRP a1-AT
Stress e 0.20 (nZ 46) 0.06 (nZ 41) 0.02 (nZ 39) 0.05 (nZ 40)
MMP-9 0.19 e 0.38* (nZ 38) 0.32* (nZ 36) 0.16 (nZ 37)
TIMP-1 0.73 0.03 e 0.39 (nZ 32) 0.55* (nZ 33)
hs-CRP 0.92 0.01 0.09 e 0.17 (nZ 39)
a1-AT 0.77 0.37 < 0.01 0.32 e
Table 4 Partial correlation coefficient matrix between AAA growth and log levels of MMP-9, TIMP-1, hs-CRP and a1-AT. The
upper right part shows the correlation coefficients and the number of measurements, the lower left part shows the corre-
sponding p-values. The * indicates a significant correlation.
AAA Growth rate MMP-9 TIMP-1 hs-CRP a1-AT
AAA Growth rate e 0.32* (nZ 46) 0.12 (nZ 41) 0.06 (nZ 39) 0.00 (nZ 40)
MMP-9 <0.05 e 0.39* (nZ 38) 0.40* (nZ 36) 0.14 (nZ 37)
TIMP-1 0.51 0.02 e 0.38 (nZ 32) 0.55* (nZ 33)
hs-CRP 0.72 0.02 0.08 e 0.17 (nZ 39)
a1-AT 0.99 0.42 <0.01 0.31 e
AAA Wall Stress, Growth and Biomarkers 415possibly reflecting the fact that both biomarkers respond to
AAA related events; namely inflammation and matrix
degradation. Furthermore, TIMP-1 was negatively corre-
lated with MMP-9. Normally, TIMP-1 regulates the activity
of MMP-9. This regulation may be disturbed in patients with
AAA, resulting in a lower TIMP-1 concentration for higher
MMP-9 levels. TIMP-1 and a1-AT were also negatively
correlated. The pathophysiological meaning is not clear,
but it was previously postulated that both MMP-9 and a1-AT
positively correlated with AAA growth.13,17 However, in the
current study, only MMP-9 showed a positive correlation
with AAA growth. Future research is required to establish
the underlying relations between these biomarkers and
their role in AAA pathophysiology.
This study is the first to couple AAA biomechanics and
biomarker information. Nevertheless, some limitations and
future research suggestions need to be mentioned. First, all
measurements in this study are treated as individual and
independent, although repeated measurements were per-
formed in the patient group. It may well be that the stress
and biomarker information is not independent per patient.
The analyses are repeated with only one, randomly selected
measurement per patient and the same trends were identi-
fied. However, no significant correlations could be found due
to the small sample size. Also, ANOVA repeated measure-
ment analyses were performed with all patients with three
measurements. Again, the same trends were found, but due
to the small sample size, no significance was reached inmost
cases. As the same trends were found, we are confident that
the stress and biomarker measurements can be treated as
independent measurements.
The AAA growth rate in this research was determined
based on the maximum anterior-posterior diameter, which
is currently the gold standard to determine the size of an
AAA. The 3D models could be used to determine more
sophisticated growth measures, based on the largestdiameter perpendicular to the central axis or the AAA
volume. However, these measures showed a considerable
variation, in the same order as the growth rate itself. The
determination of the maximum diameter is also subject to
measuring errors and user variations. Future developments
in 3D analysis tools may lead to more accurate and repro-
ducible AAA growth rates.
Although it was previously shown that wall stress is
a potentially better AAA rupture risk criterion than the
maximum diameter,7,10 AAA wall stress, as a stand-alone
marker, may not be specific enough. Wall thickness varia-
tion, material heterogeneity, intraluminal thrombus and
aortic calcifications are not included in the present simu-
lations. Currently, no noninvasive techniques are available
that can give information on the local wall thickness and
material behavior. Implementation of thrombus and calci-
fications is debatable as the material properties, material
model and interaction between thrombus, calcifications
and AAA wall remain unknown.18,19 Including these patient-
specific factors may increase the specificity of wall stress
simulations in the future.
Most biomechanical considerations of AAA’s have
focused on computing stresses acting on the aneurysm wall
and not on the wall strength. This is, however, an equally
important part in rupture risk prediction, since rupture
occurs when the stresses exceed the strength of the wall.
Information on the local wall constituents, for instance by
means of MRI or advanced molecular imaging may
substantially contribute to wall strength estimations and
therefore to future AAA rupture risk analysis.
It must be noted that the relations found in this study
only apply for AAA’s with diameters between 40 and 55 mm,
and cannot directly be extrapolated to smaller or larger
AAA’s. The current analysis was limited by a relative small
patient group, representing AAA’s with the most clinically
relevant diameter. Extending the study with AAA’s with
416 L. Speelman et al.a wider range in diameter may give more insight in the
general relations between wall stress, AAA growth and
biomarkers.
Conclusion
To our knowledge, this is the first study that combines both
circulating biomarker information and wall stress informa-
tion with the prospective growth rate of AAA’s. A relative
medium or high wall stress was associated with a higher
growth rate compared to a relative low wall stress
(medium-low p-value 0.02, high-low p-value 0.08). The
MMP-9 plasma concentration positively correlated to AAA
growth rate (p-value <0.05). No correlation was found
between absolute or relative wall stress and biomarker
concentrations analyzed in this study, although the average
concentrations of MMP-9 and hs-CRP showed an increase for
higher relative wall stress. Further analysis is warranted to
verify the relation between AAA wall stress, growth rate
and biomarker concentrations.
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